Last edition
News about "Andrew Henderson"
Sterling Pharma Solutions Expands UK Bioconjugation Capacity
Sterling Pharma Solutions completes a new 500L GMP manufacturing suite at its bioconjugation facility in Deeside, UK.
Andrew Henderson | 06/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members